HLB Pharmaceutical

HLB제약 · 047920

Health Care Biotechnology · KOSDAQ

Small-cap

Market cap US$275.9M (₩380.8B)

Overview

Company summary coming soon.

Source: DART · FY ending Dec · latest FY2025

Revenue · FY2025

US$149M

▲ +50.0% YoY

Operating profit · FY2025

US$770.9K

▼ −27.8% YoY

Net income · FY2025

US$3.3M

▲ +126.3% YoY

Revenue, operating profit and net income by fiscal year (USD; KRW in parentheses).
Metric	FY2023	FY2024	FY2025
Revenue	US$98.5M(₩136B)	US$99.3M(₩137.1B)	US$149M(₩205.6B)
Operating profit	−US$14.2M(−₩19.5B)	US$1.1M(₩1.5B)	US$770.9K(₩1.1B)
Net income	−US$14.1M(−₩19.4B)	US$1.5M(₩2B)	US$3.3M(₩4.6B)

Revenue

Operating profit

Net income

ROE

3.6%

Debt/Eq

36.4%

Op. margin

0.5%

Net margin

2.2%

Rev. YoY

▲ +50.0%

Interactive price history isn't here yet. Would you use it?